Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Open Label Study to Establish the Safety and Efficacy of Intravenous Loading Dose of Ibandronate 6 mg in 3 Consecutive Days in Breast Cancer Patients With Skeletal Metastases

NCT00381368 is registered in ClinicalTrials.gov with University of Turku as lead sponsor.

NCT NCT00381368
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00381368 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Open Label Study to Establish the Safety and Efficacy of Intravenous Loading Dose of Ibandronate 6 mg in 3 Consecutive Days in Breast Cancer Patients With Skeletal Metastases
Lead sponsor
University of Turku
Phase
Phase 2
Overall status
Unknown status
Start date
October 31, 2006
Completion date
Not reported
Enrollment
60
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer